Yaal-Hahoshen N - Search Results

1

Fulvestrant in heavily pretreated metastatic breast cancer: is it still effective as a very advanced line of treatment?

Safra T, Greenberg J, Ron IG, Ben-Yosef R, Inbar M, Sarid D, Yaal-Hahoshen N. Safra T, et al. Among authors: yaal hahoshen n. Isr Med Assoc J. 2008 May;10(5):339-43. Isr Med Assoc J. 2008. PMID: 18605354 Free article.

2

Preoperative clinical, mammographic and sonographic assessment of neoadjuvant chemotherapy response in breast cancer.

Sperber F, Weinstein Y, Sarid D, Ben Yosef R, Shalmon A, Yaal-Hahoshen N. Sperber F, et al. Isr Med Assoc J. 2006 May;8(5):342-6. Isr Med Assoc J. 2006. PMID: 16805235 Free article.

3

Herceptin (trastuzumab): adjuvant and neoadjuvant trials.

Yaal-Hahoshen N, Safra T. Yaal-Hahoshen N, et al. Isr Med Assoc J. 2006 Jun;8(6):416-21. Isr Med Assoc J. 2006. PMID: 16833172 Free article. Review. No abstract available.

4

Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II study.

Sarid D, Ron IG, Sperber F, Stadler Y, Kahan P, Kovner F, Ben-Yosef R, Marmor S, Grinberg Y, Maimon N, Weinstein J, Yaal-Hahoshen N. Sarid D, et al. Clin Drug Investig. 2006;26(12):691-701. doi: 10.2165/00044011-200626120-00003. Clin Drug Investig. 2006. PMID: 17274676 Clinical Trial.

5

Invasive breast cancer treated with taxol and epirubicin neo-adjuvant chemotherapy: the role in the outcome of the "crosstalk" between Erb receptors and p53.

Sarid D, Ron IG, Shoshan L, Barnea I, Shina S, Baratz M, Greenberg J, Merimsky O, Ben-Yosef R, Lev-Ari S, Keidar Y, Yaal-Hahoshen N. Sarid D, et al. Among authors: yaal hahoshen n. Anticancer Res. 2008 Sep-Oct;28(5B):3147-52. Anticancer Res. 2008. PMID: 19031973 Free article. Clinical Trial.

6

Nuclear and cytoplasmic expression of ErbB-4 in prostate cancer.

Ben-Yosef R, Sarid D, Vexler A, Lidawi G, Inbar M, Marmor S, Starr A, Yaal Hahoshen N. Ben-Yosef R, et al. Int J Biol Markers. 2007 Jul-Sep;22(3):181-5. doi: 10.1177/172460080702200303. Int J Biol Markers. 2007. PMID: 17922460 Free article.

7

Effect of Chinese herbal therapy on breast cancer adenocarcinoma cell lines.

Maimon Y, Karaush V, Yaal-Hahoshen N, Ben-Yosef R, Ron I, Vexler A, Lev-Ari S. Maimon Y, et al. Among authors: yaal hahoshen n. J Int Med Res. 2010;38(6):2033-9. doi: 10.1177/147323001003800617. J Int Med Res. 2010. PMID: 21227007 Free article.

8

Dead Sea products.

Ben-Yosef R, Yaal-Hahoshen N. Ben-Yosef R, et al. Isr Med Assoc J. 2007 Oct;9(10):765. Isr Med Assoc J. 2007. PMID: 17987774 Free article. No abstract available.

9

A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer.

Yaal-Hahoshen N, Maimon Y, Siegelmann-Danieli N, Lev-Ari S, Ron IG, Sperber F, Samuels N, Shoham J, Merimsky O. Yaal-Hahoshen N, et al. Oncologist. 2011;16(9):1197-202. doi: 10.1634/theoncologist.2011-0150. Epub 2011 Jun 28. Oncologist. 2011. PMID: 21712486 Free PMC article. Clinical Trial.

10

Decreased prevalence of asymptomatic choroidal metastasis in disseminated breast and lung cancer: argument against screening.

Barak A, Neudorfer M, Heilweil G, Merimsky O, Lowenstein A, Inbar M, Yaal-Hahoshen N. Barak A, et al. Br J Ophthalmol. 2007 Jan;91(1):74-5. doi: 10.1136/bjo.2006.099416. Epub 2006 Aug 30. Br J Ophthalmol. 2007. PMID: 16943227 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters